Ondansetron Hydrochloride

5 trials 1 recruiting AGastroenterology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

3 Completed trials

5 Sponsors

7 Countries

Phase II

Phase I/II

Phase IV

Phase I (FiH)

Phase II: 2 Phase I/II: 1 Phase IV: 1 Phase I (FiH): 1

Oversight events:

1 urgent safety measure across 1 trial

View oversight register →

Indications tested

Glycogen storage disease type I 1 Metastasis 1

Sponsors using this IMP

AstraZeneca AB 1 Centre Hospitalier Universitaire De Nantes 1 Eli Lilly & Co. 1 Moderna Inc. 1 Synthorx Inc. 1

All trials

5 total

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer Pending

2025-522204-24-00 Phase II 4 countries Eli Lilly & Co.
Avoid With locoregional Analgesia Persistant Postoperative Pain After Surgery In Children Recruiting

2023-503499-25-00 Phase IV 1 country Centre Hospitalier Universitaire De Nantes
A weight loss study evaluating subcutaneous treatment withAZD9550 and AZD6234 in combination, against placebo or each of the drugs alone Ended

2024-516176-15-00 Phase II 1 country AstraZeneca AB
A Phase 1/2, adaptive, open-label, single ascending dose to multiple ascending dose study to evaluate the safety, tolerability, pharmacokine… Ended

2022-502963-39-00 Phase I (FiH) 4 countries Moderna Therapeutics Inc.
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) Ended

2023-508422-95-00 Phase I/II 1 country Synthorx Inc.

Showing 1–5 of 5 trials

← All drugs A–Z